REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,246,000 | +54.4% | 68,569 | +24.3% | 0.02% | +69.2% |
| Q4 2021 | $1,455,000 | -70.5% | 55,172 | +12.7% | 0.01% | -71.7% |
| Q3 2021 | $4,924,000 | -30.1% | 48,935 | -1.7% | 0.05% | -29.2% |
| Q2 2021 | $7,042,000 | +63.0% | 49,757 | +14.9% | 0.06% | +51.2% |
| Q1 2021 | $4,319,000 | -14.9% | 43,320 | +5.5% | 0.04% | -15.7% |
| Q4 2020 | $5,075,000 | +35.8% | 41,056 | +7.0% | 0.05% | +21.4% |
| Q3 2020 | $3,738,000 | -37.4% | 38,370 | +0.2% | 0.04% | -40.8% |
| Q2 2020 | $5,975,000 | +53.0% | 38,298 | +41.5% | 0.07% | +29.1% |
| Q1 2020 | $3,906,000 | -12.7% | 27,059 | +23.6% | 0.06% | +12.2% |
| Q4 2019 | $4,476,000 | +420.5% | 21,894 | +104.3% | 0.05% | +390.0% |
| Q3 2019 | $860,000 | -14.9% | 10,716 | 0.0% | 0.01% | -16.7% |
| Q2 2019 | $1,011,000 | – | 10,716 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |